FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981040379> ?p ?o ?g. }

• W1981040379 endingPage "359" @default.
• W1981040379 startingPage "350" @default.
• W1981040379 abstract "We have examined the effect of neutralizing TGF-beta antibodies on cisplatin-mediated cytotoxicity against MDA-231 human breast tumor cell spheroids. These tridimensional in vitro systems have been shown to recapitulate the drug sensitivity pattern of tumor cells in vivo. MDA-231 tumor cell spheroids exhibit higher protein levels of the cyclin-dependent kinase (Cdk) inhibitors p21 and p27 and >10-fold lower Cdk2 activity compared to adherent cell monolayers, as well as pRb hypophosphorylation, a predominant G1 population, and a cisplatin 1-h IC50 of approximately 100 microM. Treatment of MDA-231 cells in monolayer with cisplatin for 1 h, subsequently grown as spheroids, increased steady-state TGF-beta1 mRNA levels, secretion of active TGF-beta, cellular Cdk2 activity, pRb phosphorylation, and p21 protein levels, while downregulating p27. Accumulation of cells in G2M and progression into S were noted 48 h after treatment with 100 microM cisplatin. We tested whether drug-induced upregulation of TGF-beta1 and p21, perhaps by preventing cell cycle progression, were protective mechanisms against drug-mediated toxicity by using neutralizing anti-TGF-beta antibodies. Anti-TGF-beta antibodies diminished the induction of p21, enhanced the activation of Cdk2, and facilitated progression into S and G2M following cisplatin treatment. This resulted in a >twofold enhancement of drug-induced DNA fragmentation and a shift in the cisplatin 1-h IC50 from 100 to <10 microM. These data suggest that tumor cell TGF-beta1 may protect from DNA damage and that postchemotherapy administration of TGF-beta inhibitors may facilitate progression beyond G1/S, potentially increasing the efficacy of cytotoxic chemotherapy." @default.
• W1981040379 created "2016-06-24" @default.
• W1981040379 creator A5009618044 @default.
• W1981040379 creator A5025544363 @default.
• W1981040379 creator A5043946489 @default.
• W1981040379 creator A5048451600 @default.
• W1981040379 date "1998-12-01" @default.
• W1981040379 modified "2023-09-25" @default.
• W1981040379 title "Blockade of Tumor Cell Transforming Growth Factor-βs Enhances Cell Cycle Progression and Sensitizes Human Breast Carcinoma Cells to Cytotoxic Chemotherapy" @default.
• W1981040379 cites W1965104493 @default.
• W1981040379 cites W1969672566 @default.
• W1981040379 cites W1978480311 @default.
• W1981040379 cites W1979877257 @default.
• W1981040379 cites W1983075270 @default.
• W1981040379 cites W1983332906 @default.
• W1981040379 cites W1983589855 @default.
• W1981040379 cites W1991512313 @default.
• W1981040379 cites W1998335540 @default.
• W1981040379 cites W2004236941 @default.
• W1981040379 cites W2008117987 @default.
• W1981040379 cites W2014910631 @default.
• W1981040379 cites W2018614002 @default.
• W1981040379 cites W2023300542 @default.
• W1981040379 cites W2030841985 @default.
• W1981040379 cites W2035641694 @default.
• W1981040379 cites W2037065421 @default.
• W1981040379 cites W2038809726 @default.
• W1981040379 cites W2041585886 @default.
• W1981040379 cites W2046829382 @default.
• W1981040379 cites W2048036622 @default.
• W1981040379 cites W2050552549 @default.
• W1981040379 cites W2053235012 @default.
• W1981040379 cites W2059658446 @default.
• W1981040379 cites W2062076206 @default.
• W1981040379 cites W2063599502 @default.
• W1981040379 cites W2068302691 @default.
• W1981040379 cites W2083554413 @default.
• W1981040379 cites W2088666448 @default.
• W1981040379 cites W2089687291 @default.
• W1981040379 cites W2090291556 @default.
• W1981040379 cites W2095308442 @default.
• W1981040379 cites W2103385168 @default.
• W1981040379 cites W2112555367 @default.
• W1981040379 cites W2113832454 @default.
• W1981040379 cites W2131405836 @default.
• W1981040379 cites W2138351184 @default.
• W1981040379 cites W2146839556 @default.
• W1981040379 cites W2255395527 @default.
• W1981040379 cites W2325103672 @default.
• W1981040379 cites W4211166816 @default.
• W1981040379 doi "https://doi.org/10.1006/excr.1998.4261" @default.
• W1981040379 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9851876" @default.
• W1981040379 hasPublicationYear "1998" @default.
• W1981040379 type Work @default.
• W1981040379 sameAs 1981040379 @default.
• W1981040379 citedByCount "83" @default.
• W1981040379 countsByYear W19810403792012 @default.
• W1981040379 countsByYear W19810403792013 @default.
• W1981040379 countsByYear W19810403792014 @default.
• W1981040379 countsByYear W19810403792015 @default.
• W1981040379 countsByYear W19810403792016 @default.
• W1981040379 countsByYear W19810403792017 @default.
• W1981040379 countsByYear W19810403792019 @default.
• W1981040379 countsByYear W19810403792020 @default.
• W1981040379 countsByYear W19810403792023 @default.
• W1981040379 crossrefType "journal-article" @default.
• W1981040379 hasAuthorship W1981040379A5009618044 @default.
• W1981040379 hasAuthorship W1981040379A5025544363 @default.
• W1981040379 hasAuthorship W1981040379A5043946489 @default.
• W1981040379 hasAuthorship W1981040379A5048451600 @default.
• W1981040379 hasConcept C118131993 @default.
• W1981040379 hasConcept C121608353 @default.
• W1981040379 hasConcept C124320809 @default.
• W1981040379 hasConcept C134018914 @default.
• W1981040379 hasConcept C1491633281 @default.
• W1981040379 hasConcept C2776694085 @default.
• W1981040379 hasConcept C2778229498 @default.
• W1981040379 hasConcept C2778239845 @default.
• W1981040379 hasConcept C2778298596 @default.
• W1981040379 hasConcept C2779256057 @default.
• W1981040379 hasConcept C29537977 @default.
• W1981040379 hasConcept C502942594 @default.
• W1981040379 hasConcept C54355233 @default.
• W1981040379 hasConcept C55493867 @default.
• W1981040379 hasConcept C62112901 @default.
• W1981040379 hasConcept C82495950 @default.
• W1981040379 hasConcept C86803240 @default.
• W1981040379 hasConceptScore W1981040379C118131993 @default.
• W1981040379 hasConceptScore W1981040379C121608353 @default.
• W1981040379 hasConceptScore W1981040379C124320809 @default.
• W1981040379 hasConceptScore W1981040379C134018914 @default.
• W1981040379 hasConceptScore W1981040379C1491633281 @default.
• W1981040379 hasConceptScore W1981040379C2776694085 @default.
• W1981040379 hasConceptScore W1981040379C2778229498 @default.
• W1981040379 hasConceptScore W1981040379C2778239845 @default.
• W1981040379 hasConceptScore W1981040379C2778298596 @default.
• W1981040379 hasConceptScore W1981040379C2779256057 @default.
• W1981040379 hasConceptScore W1981040379C29537977 @default.

• next